Cerebras Faces Its First Earnings Test: A $24.6 Billion Backlog Meets a 95x Price Tag

The chipmaker Cerebras Systems steps into the earnings spotlight on Tuesday with its first quarterly report since going public — and the stock has already started to price in optimism. Shares jumped nearly 10% on Friday to $234.71, a clear signal that investors are positioning for what many see as the company’s defining moment as a listed entity.

Wall Street is bracing for red ink. Analysts polled by consensus expect a loss of 14 cents per share on revenue of roughly $56.65 million for the fiscal first quarter of 2026. That top line looks modest compared with the $510 million Cerebras booked for the full year 2025, but lumpy hardware orders make quarterly swings a given. The real headline, however, isn’t the quarter itself — it’s the staggering order pipeline.

The $24.6 Billion Question

Cerebras carries a backlog of 24.6 billion dollars in contracted and anticipated orders. For a company with a market capitalization of $51.5 billion and a price-to-sales ratio of 95, that backlog is both the bull case and the biggest source of risk. Investors will scrutinize how fast management can convert those bookings into recognized revenue — and whether the timeline runs into 2026, 2027, or further out.

A single quarter’s revenue of $57 million or so barely scratches the surface of that pile. The conversion rate will dictate whether the stock can justify its extreme valuation or if a reality check is overdue.

Hanging on the UAE

Cerebras’s customer concentration remains its most glaring vulnerability. Last year, roughly 86% of revenue came from just two clients in the United Arab Emirates: 62% from the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) and 24% from the tech conglomerate G42. That level of dependence leaves the company exposed to the whims of a handful of counterparties. Any pause in spending, a renegotiation, or a switch in suppliers would hit the stock instantly.

The market is watching for signs of diversification — a broader customer base that could reduce this single-region reliance. Without it, Cerebras remains a bet on Abu Dhabi’s appetite for AI hardware.

Should investors sell immediately? Or is it worth buying CEREBRAS SYSTEMS INC - A?

Margins Headed the Wrong Way

Profitability is another sore spot. Cerebras’s gross margin slipped from 42% to 39% year over year. The pressure comes from its unconventional chip design: wafer-scale processors that are far more complex and prone to defects than traditional semiconductors. The margin trajectory will set the tone for the full year. A continued decline would raise serious questions about the path to sustainable profitability, despite the growth narrative.

Adding to the near-term noise, a lock-up provision threatens to unleash a wave of insider selling. More than 60 million shares become eligible for early release once the market cap exceeds $40 billion — a threshold Cerebras has already crossed. That unusual clause could inject significant supply into the market, especially as the first public financial data hits screens.

Competition Heats Up — But Analysts Stay Bullish

The competitive landscape is also hardening. Nvidia’s acquisition of inference specialist Groq for $20 billion marks a direct incursion into Cerebras’s turf. The company also faces off against AMD, Google, AWS, Microsoft, Meta, and chip designers Broadcom and Marvell. Cerebras has carved a niche targeting hyperscalers and national labs seeking Nvidia alternatives — a real but narrow market.

Despite these headwinds, the analyst community is unanimous in its enthusiasm. All ten analysts covering the stock rate it a Buy. The average price target sits at $294, with the highest at $340. Investment banks including Morgan Stanley, UBS, Wedbush, Citigroup, Barclays, and Needham have initiated coverage with positive ratings after the quiet period ended. Craig-Hallum set a target of $325, citing insatiable demand for fast AI chips.

The long-term growth projections are ambitious: revenues are expected to compound at 43.8% annually and earnings per share at 48.4%. Tuesday’s report will be the first hard check on those forecasts — and for a stock trading at 95 times sales, there is zero margin for error.